Forty people in Gambia who tested positive for COVID-19 over the past week have refused to self-isolate or have escaped treatment centers, according to the country's health ministry, which vowed to reveal the identities of those flouting public health regulations.

Officials are also aware of a "large number of travelers who recently arrived" in the small West African nation from countries considered COVID-19 hotspots and "have refused to abide to official protocols and/or report to the health authorities for the mandatory test upon arrival," said Modou Njai, director of health promotion and education at Gambia's Ministry of Health.

"The Ministry continues to treat these matters with utmost and grave concern and thus, the Ministry is hereby giving an order and ultimatum to all those concerned, that they are required to report themselves to the health authorities with immediate effect and failure of which will lead to serious consequences, including the publication of names and identifying information of all those at large," Njai said in a statement Tuesday.

"The Ministry would like to stress that this serious and ruthless misconduct will no longer be condoned under any circumstances," he added. "Anyone found not willing to cooperate with COVID-19 regulations will have their names and identifying information published on the media and thereafter, drastic measures will be taken against anyone that is non-compliant."

Gambia, home to some 2.3 million people, has confirmed 4,008 cases of COVID-19 since the start of the pandemic, including at least 128 deaths, according to the latest data from the health ministry.

There were 142,511 new cases of COVID-19 confirmed in the United States on Tuesday, according to a real-time count kept by Johns Hopkins University.

Tuesday's case count is far less than the country's all-time high of 298,031 newly confirmed infections on Jan. 2, Johns Hopkins data shows.

An additional 3,990 fatalities from COVID-19 were registered nationwide on Tuesday, down from a peak of 4,462 new deaths on Jan. 12, according to Johns Hopkins data.

COVID-19 data may be skewed due to possible lags in reporting over the Martin Luther King Jr. Day holiday weekend.

A total of 25,443,700 people in the U.S. have been diagnosed with COVID-19 since the pandemic began, and at least 425,216 have died, according to Johns Hopkins data. The cases include people from all 50 U.S. states, Washington, D.C., and other U.S. territories as well as repatriated citizens.

Much of the country was under lockdown by the end of March as the first wave of pandemic hit. By May 20, all U.S. states had begun lifting stay-at-home orders and other restrictions put in place to curb the spread of the novel coronavirus. The day-to-day increase in the country's cases then hovered around 20,000 for a couple of weeks before shooting back up over the summer.

The numbers lingered around 40,000 to 50,000 from mid-August through early October before surging again to record levels, crossing 100,000 for the first time on Nov. 4, then reaching 200,000 on Nov. 27 before nearing 300,000 on Jan. 2.

So far, the U.S. Food and Drug Administration has authorized two COVID-19 vaccines for emergency use -- one developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech, and another developed by American biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases.

COVID-19 hospitalizations in the United States continue to trend downward, but the country's daily death rate is still above 3,000, according to The COVID Tracking Project, a volunteer-run effort to track the U.S. outbreak.

There are 108,957 people currently hospitalized with COVID-19 in the U.S., which is almost 30,000 fewer cases than a couple of weeks ago, the group said.

The country's seven-day average of daily COVID-19 deaths is now at 3,302, according to The COVID Tracking Project.

"While cases and hospitalizations are falling, the 7-day average for deaths jumped up today. That's because last Tuesday's data was depressed by the holiday," the group wrote on Twitter Tuesday. "We do expect, however, that deaths could stay elevated for quite a while."

U.S. President Joe Biden's administration said it has secured commitments from manufacturers to buy another 200 million doses of COVID-19 vaccines to arrive this summer -- 100 million from Pfizer and 100 million from Moderna.

This raises the total to 600 million and ensures the U.S. will eventually have two shots for nearly every American.

"We expect these vaccines to be available in production over the course of the summer," a Biden official said Tuesday.

Buying more doses had always been an option for the U.S. government as part of the prior contracts.

"We will increase overall weekly vaccination distributions of states, tribes and territories from 8.6 million doses to a minimum of 10 million doses starting next week," Biden said Tuesday.

The president also vowed to increase "transparency with states, cities and tribes and local partners when it comes to the vaccine supply."

"From this week forward," he said, "states, tribes and territories will now always have a reliable, three-week forecast with the supply they're going to get."

ABC News’ Anne Flaherty contributed to this report.